<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the frequency of occurrence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> concurrently with temporal <z:hpo ids='HP_0012089'>arteritis</z:hpo> (TA), as well as features and outcome of the <z:hpo ids='HP_0002633'>vasculitis</z:hpo> in such cases </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In a series of 271 consecutive patients with TA (219 biopsy-proven), we retrospectively analyzed the frequency and type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> concurrent with <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (less than 1 year before or after), as well as the main features and outcome of TA in this setting </plain></SENT>
<SENT sid="2" pm="."><plain>We also surveyed <z:hpo ids='HP_0000001'>all</z:hpo> cases published in the French-British literature </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We observed 20 patients with TA and concurrent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and reviewed 27 similar published reports </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e> was documented pathologically in 86% of the cases </plain></SENT>
<SENT sid="5" pm="."><plain>The time between diagnosis of TA and that of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> averaged 3.5 months (synchronous diagnoses in 27 patients) </plain></SENT>
<SENT sid="6" pm="."><plain>Various locations of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were found, particularly the gastrointestinal tract (9 cases); blood <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> accounted for 45% of cases (lymphoid disorder in 9, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in 11, <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> in 1) </plain></SENT>
<SENT sid="7" pm="."><plain>In our patients, logistic regression analysis failed to demonstrate differences between those with and without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, except for a higher frequency of rheumatic involvement in the former group (60% vs 30%; p = 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>The initial response to steroid treatment was good in 92% of 40 assessable patients, and the <z:hpo ids='HP_0002633'>vasculitis</z:hpo> course mirrored that of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in only 2 patients </plain></SENT>
<SENT sid="9" pm="."><plain>Regarding the outcome of TA, no differences were observed in our patients with and without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Concurrent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in TA is not a rare finding, being observed in up to 7.4% of the cases </plain></SENT>
<SENT sid="11" pm="."><plain>Solid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, especially <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, may represent precipitating factors for development of TA, which infrequently run a paraneoplastic course </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with and without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> seem almost indistinguishable regarding features and outcome of TA </plain></SENT>
<SENT sid="13" pm="."><plain>Physicians who care for patients with TA should be mindful of this potential association, even in typical cases </plain></SENT>
</text></document>